AI in Healthcare

The pharmaceutical industry is undergoing a profound transformation, with AI at its core. New reports indicate that AI is drastically shortening drug discovery timelines, with some companies now developing drug candidates in as little as one year, a significant leap from the traditional 4.5 years. This efficiency extends to clinical trials, where AI-native platforms are cutting study build times from weeks to hours, accelerating the entire development pipeline. What are the most critical implications of this accelerated pace for patient care and market competition? This insight draws from 'AI shortens drug discovery to around 1 year in China, Insilico CEO says' by Thomson Reuters (Published July 23, 2026) and 'Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios' by Medidata (Published July 23, 2026, https://www.medidata.com/news/medidata-plus-launch-2026-07-23 [BREAKING]). View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google and IBM-Trained. Cross Domain-Expert. Quantum AI Educator. Solepoint (Facts Already Defined) Strategic Practitioner. Real Estate Intelligence Leader. VUI Native AI Cloud Architect. AI Certifications Development. George Arnold Alexander III Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC +1 713.918.9951 · [email protected]